VEON
VEON Ltd.
There isn't enough reported data to score VEON yet.
VZ
Verizon Communications Inc.
VZ's fundamentals are mixed: it turned 28% of its revenue into free cash flow, but its operating margin fell 2 points to 21%. At 12x earnings, it's trading in line with its usual 11x. Analysts expect earnings growth.
VEON Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Strong | |
| Unavailable | |
| Healthy |
VEON's profitability and balance sheet are currently healthy. There isn't enough data to rate its revenue and cash flow.
VZ Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Under pressure |
VZ's profitability and cash flow are currently healthy, and its revenue is stable, but its balance sheet is under pressure.
VEON PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.5x | $63.62 | -15% |
| Fair | 8.5x | $83.40 | +11% |
| Current | 9.8x | $75.15 | — |
| Expensive | 10x | $103 | +37% |
Historical ranges are pointers, not guarantees.
VEON's PE is 9.8x, but its earnings don't support one, so it isn't a reliable read right now.
VZ PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.3x | $32.43 | -30% |
| Forward | 9x | $46.55 | — |
| Fair | 11x | $43.63 | -6.3% |
| Current | 12x | $46.55 | — |
| Expensive | 14x | $56.75 | +22% |
Historical ranges are pointers, not guarantees.
VZ has the edge over VEON in the historical PE scenario, which offers more potential upside but is not a forecast.
VEON Forward outlook
There aren't enough analyst estimates for VEON to show an outlook.
VZ Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect VZ's earnings to grow and its profitability to improve, with its revenue holding steady.
VEON Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | $9.82 | +409% |
| Q2 2025 | $10.07 | +$10.08 |
| Q1 2025 | $2.53 | -2.3% |
| Q4 2024 | $1.93 | -71% |
| Q4 2023 | $6.67 | +$8.92 |
| Q4 2022 | -$2.25 | -123% |
| Q4 2021 | $9.75 | +$14.73 |
| Q4 2020 | -$4.98 | -155% |
VEON has the edge over VZ in the latest year-over-year earnings comparison.
VZ Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.19 | +32% |
| Q3 2026 | $3.93 | -16% |
| Q2 2026 | $3.85 | -10% |
| Q1 2026 | $4.11 | -2.1% |
| Q4 2025 | $4.06 | -1.9% |
| Q3 2025 | $4.68 | +103% |
| Q2 2025 | $4.29 | +61% |
| Q1 2025 | $4.20 | +57% |
| Q4 2024 | $4.14 | +51% |
VZ's earnings per share have fallen from their peak: $3.93 over the past year, against $5.34 in late 2021.
VEON Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $2.3B | +12% |
| Q2 2025 | $1.1B | +5.8% |
| Q1 2025 | $1B | +8.9% |
| Q4 2024 | $2B | +7.2% |
| Q2 2024 | $1B | +12% |
| Q1 2024 | $942M | +6.6% |
| Q4 2023 | $1.9B | -49% |
| Q4 2022 | $3.8B | -52% |
VEON has the edge over VZ in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | 17% | -10 points |
| Q2 2025 | 75% | +54 points |
| Q1 2025 | 23% | -2.1 points |
| Q4 2024 | 31% | +4.6 points |
| Q2 2024 | 27% | +3.9 points |
| Q1 2024 | 21% | -9.6 points |
| Q4 2023 | 25% | +5.6 points |
| Q2 2023 | 26% | +29 points |
VEON's operating margin was 17% last quarter, down 10 points from the same quarter a year ago.
VZ Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $34.3B | +1.5% |
| Q2 2026 | $34.3B | -0.7% |
| Q1 2026 | $34.4B | +2.9% |
| Q4 2025 | $36.4B | +2% |
| Q3 2025 | $33.8B | +1.5% |
| Q2 2025 | $34.5B | +5.2% |
| Q1 2025 | $33.5B | +1.5% |
| Q4 2024 | $35.7B | +1.6% |
VZ's revenue has held roughly level: $34.3B last quarter, up 1.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 25% | +1.3 points |
| Q2 2026 | 21% | -2.7 points |
| Q1 2026 | 24% | +0.1 points |
| Q4 2025 | 14% | -7.1 points |
| Q3 2025 | 24% | +6.2 points |
| Q2 2025 | 24% | -0.2 points |
| Q1 2025 | 24% | +1 points |
| Q4 2024 | 21% | +19 points |
VZ's operating margin was 25% last quarter, up 1.3 points from the same quarter a year ago, near the top of its range since 2019.
VEON Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | $408M | +3.6% |
| Q2 2025 | -$48M | -167% |
| Q1 2025 | $255M | +410% |
| Q4 2024 | $394M | -17% |
| Q2 2024 | $72M | -78% |
| Q1 2024 | $50M | -86% |
| Q4 2023 | $476M | +59% |
| Q4 2022 | $299M | -48% |
VEON still generates free cash flow, though less than at its 2016 peak: $1B over the past year.
VZ Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $11.5B | +2.2% |
| Q2 2026 | $10.4B | +16% |
| Q1 2026 | $8B | +2.6% |
| Q4 2025 | $9.1B | -13% |
| Q3 2025 | $11.3B | +14% |
| Q2 2025 | $9B | -5.4% |
| Q1 2025 | $7.8B | +9.9% |
| Q4 2024 | $10.4B | +20% |
VZ's free cash flow has been positive every quarter for seven years: $39B over the past year, up 1.5% from the year before.
VEON Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2459% | +1.7B shares |
| 1 year | +2439% | +1.7B shares |
| 3 years | +2488% | +1.7B shares |
| 5 years | +2464% | +1.7B shares |
| Available history | +2464% | +1.7B shares |
VEON has 1.8B diluted shares, up 2439% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | $37M |
| Q2 2025 | $44M |
| Q1 2025 | $24M |
| Q2 2024 | — |
| Q1 2024 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q2 2020 | — |
VZ Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -10M shares |
| 1 year | -1.7% | -72M shares |
| 3 years | -1.3% | -55M shares |
| 5 years | +0.4% | +17M shares |
| Available history | +0.5% | +21M shares |
VZ has the edge over VEON on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $500M |
| Q2 2026 | $1B |
| Q1 2026 | $2.5B |
VEON Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2025 | 0.8x | Very low |
| Q2 2025 | 1.9x | Healthy |
| Q1 2025 | 1.6x | Healthy |
| Q4 2024 | 0.9x | Very low |
| Q2 2024 | 2.1x | Moderate |
| Q1 2024 | 2.0x | Moderate |
| Q4 2023 | 1.1x | Healthy |
| Q4 2022 | 1.8x | Healthy |
VEON's net debt is less than a year of its operating earnings (EBITDA), down from 2.0 years a year ago.
VZ Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.3x | Elevated |
| Q2 2026 | 3.4x | Elevated |
| Q1 2026 | 3.4x | Elevated |
| Q4 2025 | 2.9x | Moderate |
| Q3 2025 | 2.8x | Moderate |
| Q2 2025 | 3.0x | Moderate |
| Q1 2025 | 3.0x | Elevated |
| Q4 2024 | 3.0x | Elevated |
VZ's net debt is about 3.3 years of its operating earnings (EBITDA), up from 2.8 years a year ago.
VEON Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.7 | Neutral |
| Stochastic | 70.6 | Neutral |
VEON's weekly RSI is 65 (neutral) and its Stochastic is 71 (neutral).
VZ Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.9 | Neutral |
| Stochastic | 44.6 | Neutral |
VZ's weekly RSI is 51 (neutral) and its Stochastic is 45 (neutral).
VEON PE vs Communication Services Sector
| Metric | VEON | Sector median | Relative |
|---|---|---|---|
| PE | 9.8x | 16x | 41% below |
| PE % | 77 | 26 | 51 pts above |
VEON has the edge over VZ on valuation relative to its sector.
VZ PE vs Communication Services Sector
| Metric | VZ | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 16x | 28% below |
| PE % | 58 | 26 | 32 pts above |
VZ is trading at 12x earnings, a 28% discount to the Communication Services sector's median of 16x.
VEON Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $78.4 | 4.2% below |
| 20 week MA | $66.1 | 14% above |
| 50 week MA | $57.9 | 30% above |
| 100 week MA | $52.9 | 42% above |
| 200 week MA | $37.7 | 100% above |
VEON's trend is up, with a small recent dip: it's below only its 8-week average, and 100% above its 200-week average.
VZ Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $45.1 | 3.1% above |
| 20 week MA | $46.3 | 0.5% above |
| 50 week MA | $46.1 | 1.1% above |
| 100 week MA | $44.2 | 5.4% above |
| 200 week MA | $41.4 | 12% above |
VZ has the edge over VEON on trend strength, trading above more of its moving averages.
VEON Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $63.3 | $40.3 | -36% |
| 2021 | $40.3 | $41.8 | +3.7% |
| 2022 | $41.8 | $11.5 | -72% |
| 2023 | $11.5 | $19.7 | +71% |
| 2024 | $19.7 | $39.0 | +98% |
| 2025 | $39.0 | $52.7 | +35% |
| 2026 YTD | $52.7 | $75.2 | +43% |
VEON has the edge over VZ on returns for 2026, with the stronger performance.
VZ Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $61.5 | $58.8 | -4.4% |
| 2021 | $58.8 | $52.7 | -10% |
| 2022 | $52.7 | $38.4 | -27% |
| 2023 | $38.4 | $37.7 | -1.8% |
| 2024 | $37.7 | $39.9 | +5.9% |
| 2025 | $39.9 | $40.5 | +1.4% |
| 2026 YTD | $40.5 | $46.6 | +15% |
VZ has finished lower in four of the last six years. It's up 15% so far in 2026.